Troy Noordenbos

California Institute for Regenerative Medicine

Also affiliated with Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias”.

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias

Research Square(2025)10.21203/rs.3.rs-7746241/v1

N/A

0.104DataRank · unranked

1 citations

Mark P. Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio +32 more

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

New England Journal of Medicine(2024)10.1056/nejmoa2401361

N/A

0DataRank · unranked

190 citations

Takeshi Sugio, Troy Noordenbos, Shuyu Shi, Philip L. Bulterys, Chih Long Liu +12 more

Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment

Blood Cancer Journal(2025)10.1038/s41408-025-01291-z

N/A

0DataRank · unranked

4 citations

Fleur A. de Groot, Stefan Böhringer, Esther J Kret, Lorraine M. de Haan, Troy Noordenbos +33 more